Report Type : Therapy Reports

Report Category : Cardiovascular

Report Subcategory : Deep Vein Thrombosis or DVT

Price : 1999.00

Date : September 2022

Deep Vein Thrombosis or DVT : Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Deep Vein Thrombosis or DVT:
A blood clot in a deep vein, usually in the legs.
This condition is serious because blood clots can loosen and lodge in the lungs. Leg pain or swelling may occur, but there may be no symptoms.
Treatments include medication and the use of compression stockings.
 
Top & Promising Drugs by Company:

1. Bristol-Myers Squibb Co- Eliquis (apixaban)
2. Bayer AG- Xarelto (rivaroxaban)
3. Sanofi- Lovenox (enoxaparin sodium)
4. Daiichi Sankyo Co Ltd- Roteas (edoxaban tosylate)
5. Boehringer Ingelheim Auslandsbeteiligungs GmbH- Pradaxa (dabigatran etexilate mesylate)
6. Bayer AG- Aspirin (aspirin DR)
7. Aspen Pharmacare Holdings Ltd- Arixtra (fondaparinux sodium)
8. Mitsubishi Tanabe Pharma Corp- Fraxiparine (nadroparin calcium)
9. Pfizer Inc- Fragmin (dalteparin sodium)
10. LEO Pharma Innohep (tinzaparin sodium)